A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
about
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenzaMultivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and miceSpecific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in miceAll-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines.Influenza A and B virus intertypic reassortment through compatible viral packaging signals.Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential.Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens.An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in miceModifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus.Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.Influenza viruses with rearranged genomes as live-attenuated vaccines.Development of an improved polykaryon-based influenza virus rescue system.Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunityDevelopment of an Alternative Modified Live Influenza B Virus Vaccine.Assessment of route of administration and dose escalation for an adenovirus-based influenza A Virus (H5N1) vaccine in chickensInfluenza a viruses from wild birds in Guatemala belong to the North American lineagePartial and full PCR-based reverse genetics strategy for influenza virusesImproved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses.Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry.Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface.The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine.Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.The prevention and control of avian influenza: the avian influenza coordinated agriculture project.Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience.The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virusRecombinant influenza vaccines.Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection.Specific temperature-induced perturbations of secondary mRNA structures are associated with the cold-adapted temperature-sensitive phenotype of influenza A virus.Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A
P2860
Q24652088-5D1A1087-A35B-4248-BADA-B39D9F4B5E8BQ27301043-F22268B1-C486-423B-8712-061E08705C31Q30357662-FF1D463D-D8A5-4045-8A59-139AD57E1084Q30363730-6E04F889-C9C6-4020-87E3-E88168DF7DC5Q30364518-0F42F720-C7B0-488D-9787-624793E42E68Q30371348-A8B0012E-3661-4362-954C-E7D6C61443F0Q30371926-6DC665D5-0351-42F2-A3F0-9C3E77BC27CCQ30372776-8EEB7F60-F661-49E4-965C-D6819EEC1922Q30373784-0B16E915-1F62-40CD-9C6A-6C505DB3EDE5Q30382650-BE47D026-BF6B-4503-85B4-6884E29817D2Q30385987-5F22621C-895C-4250-915D-8A25F752F2C1Q30390932-EA6053D0-EA0C-4DB5-B87C-CDB6884481ADQ30391974-F259A381-B005-4FBA-A33C-D292E2B0E476Q30395088-23A2EEB3-729F-43A4-96CD-A256EFD3EA23Q30395286-76447E00-15E8-420F-ADB4-E633B01A8CCEQ30399477-B59D5E69-5100-4063-B12E-B040C0250EACQ30414665-0DD95187-7BB1-4ECE-B434-1BA66BC214BFQ30427712-F66D3CAC-12FB-4419-8FB9-707646EC031AQ30533592-75D2A8FE-089D-4143-BE36-5FE7081CC035Q33648987-EBEC72F4-0EFF-436C-9800-B60813A45DE0Q33733453-C07D575B-9879-4ED2-B957-50D517F1DCA7Q34150488-51130289-E60E-454B-BDE4-DC4C5CBAC4C0Q34200134-F37A1706-ED0F-4C8C-AD8D-68D6F78C4EF3Q34431166-CC1912F6-AB45-495E-8FC9-B4D9B53C9CFAQ34547300-F0099ADA-558D-4E41-B3C7-FD95F66B19F8Q34785367-8FFA208D-6110-4176-A764-889AB368FC13Q34985416-9192E313-EE4F-4D45-BAC1-6D7327895EF6Q36146504-9D99E26F-1FFB-44A1-A250-983921216DCDQ36482772-5037D50C-51D3-440C-98E7-69B12F9230E4Q37167450-9CB5DA43-311E-421C-8925-C59A11D4A79BQ37242960-6A52407E-C5C2-4C35-A3B4-4788A7FF156CQ37456446-B9E07D12-222B-4000-B98D-168162627B27Q38076422-A37DFF33-AC3D-454D-88CA-AC097198E7F9Q39034871-734285A6-9A49-4BE3-9F96-B328407CCD8BQ40050369-3C5C7413-C9A9-455D-AD8D-16D9A7526D7AQ42059898-6079CBD2-E3AC-4892-BAE2-9F4F79CB2201Q43238615-549CABBE-B5A4-4A94-971D-3B32292136E4Q47927986-A39ACCF4-871C-4C1C-95E7-4F9E66EDE1D1Q50308620-A72528A4-DA7C-4934-9BF0-30F61530CAFBQ54690394-84A67B8F-0F31-4CCA-BE1D-821DF03180F3
P2860
A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A new generation of modified l ...... potential vaccine candidates.
@ast
A new generation of modified l ...... potential vaccine candidates.
@en
type
label
A new generation of modified l ...... potential vaccine candidates.
@ast
A new generation of modified l ...... potential vaccine candidates.
@en
prefLabel
A new generation of modified l ...... potential vaccine candidates.
@ast
A new generation of modified l ...... potential vaccine candidates.
@en
P2860
P356
P1433
P1476
A new generation of modified l ...... potential vaccine candidates.
@en
P2093
Haichen Song
P2860
P304
P356
10.1128/JVI.00893-07
P407
P577
2007-06-27T00:00:00Z